Strimvelis - autologous CD34+
- BNF:
- Not listed
- Status:
- Red
- Decision Date:
- March 2018
Comments
RED8: NICE HST7- Strimvelis for treating adenosine deaminase deficiency-severe combined immunodeficiency. (Decision date -March 2018)
Red Drug Classifications
- 8. NHS England commissioned – to be used in line with NHSE commissioning intentions
search again
